Inflection Point Acquisition Corp. V logo

IPEX

NASDAQ

Inflection Point Acquisition Corp. V

Inflection Point Acquisition Corp. V (IPEX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for IPEX in the last 30 days. The most recent was published Oct 5, 2026.

News · 26 weeks27-100%
2026-05-10: 02026-05-17: 02026-05-24: 02026-05-31: 02026-06-07: 12026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 12026-07-12: 22026-07-19: 12026-07-26: 02026-08-02: 02026-08-09: 92026-08-16: 02026-08-23: 12026-08-30: 82026-09-06: 02026-09-13: 02026-09-20: 22026-09-27: 12026-10-04: 12026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 0
2026-05-102026-11-01
Mix2290d
  • SEC Filings14(64%)
  • Other8(36%)

Latest news

25 items

IPEX FAQ

6 questions
  • What is the latest news on IPEX?
    Quantisnow has not tracked any new filings, ratings or press releases for IPEX in the last 30 days. The most recent wire item was published on October 5, 2026.
  • Where does IPEX stock trade?
    Inflection Point Acquisition Corp. V (IPEX) is listed on NASDAQ.
  • What sector and industry is IPEX in?
    Inflection Point Acquisition Corp. V operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Inflection Point Acquisition Corp. V go public?
    Inflection Point Acquisition Corp. V (IPEX) completed its IPO in 2025.
  • What companies are similar to IPEX?
    Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare IPEX side-by-side with any of them on Quantisnow.
  • How can I track IPEX on Quantisnow?
    Quantisnow aggregates Inflection Point Acquisition Corp. V's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IPEX to receive live email and push alerts on every new disclosure.